Richa, Hanna .

HRN: 27-35-78  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/22/2025
CEFUROXIME 750MG (VIAL)
06/22/2025
06/29/2025
IV
600mg
Q8
PCAP C
Pending Pharmacy Acceptance 

 Indication:  ProphylaxisEmpiric    Type of Infection:  PneumoniaBloodstreamProphylaxis    Compliance to guidelines: